Moran Kevin Patrick 4
4 · Vanda Pharmaceuticals Inc. · Filed Jul 29, 2024
Insider Transaction Report
Form 4
Moran Kevin Patrick
SVP, CFO & Treasurer
Transactions
- Sale
Common Stock
2024-07-29$5.92/sh−2,251$13,327→ 228,763 total
Holdings
- 635(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to the default "same day sale" provisions of the RSU agreements.